John Celebi - 19 Feb 2025 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
19 Feb 2025
Net transactions value
-$2,646
Form type
4
Filing time
26 Feb 2025, 18:45:30 UTC
Previous filing
14 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Tax liability $2,646 -5,558 -5% $0.4760 105,862 19 Feb 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.
F2 Includes an aggregate of 6,000 shares purchased by the Reporting Person since May 16, 2024 pursuant to the Issuer's 2021 Employee Stock Purchase Plan.